Wednesday, 27 February 2013

Yahoo! Finance: Biotechnology Industry News: Agenus' HerpV Phase 2 Study to Treat Genital Herpes Completes Enrollment

Yahoo! Finance: Biotechnology Industry News
The latest news on the Biotechnology industry from Yahoo! Finance
Agenus' HerpV Phase 2 Study to Treat Genital Herpes Completes Enrollment
Feb 27th 2013, 12:00

[GlobeNewswire] - LEXINGTON, Mass. -- Agenus Inc. , a developer of therapeutic vaccines for cancer and infectious diseases, today announced it has completed patient screening in its Phase 2 randomized, double-blind, multicenter ...

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment